Marijuana and cannabis are commonly used names for products derived from the cannabis plant. People may use them for relaxation, sleep, social connection or relief from distress, but a pattern can become difficult to control even when the original intention was occasional use. Cannabis use disorder describes a clinically significant pattern of problematic use; it cannot be diagnosed simply because someone has used cannabis or because a relative dislikes it.
This guide explains signs that deserve assessment, the role of withdrawal and the questions that help distinguish different needs. It is not a self-diagnostic test or advice about changing a prescribed medicine. The separate marijuana and cannabis treatment page describes the care pathway, while the detox resource focuses on what can happen when regular use stops.
Products and Patterns Are Not All the Same
An assessment should identify what is being used rather than rely on the word weed. Products differ in their composition, potency and route of use. Smoking, vaping and eating a cannabis product also involve different patterns of exposure. Information from packaging may be useful when available, but products obtained outside regulated supply may not contain exactly what the person expects.
Tell the clinician about frequency, amount as best you can describe it, time of day and the reason for each episode. Someone using every evening to sleep may have different questions from someone repeatedly using throughout the day. Synthetic cannabinoid products should not be assumed to have the same risks or withdrawal course as plant-derived cannabis. Report uncertainty about the product rather than choosing a familiar label.
What Makes Use Problematic?
The assessment considers impaired control, repeated unsuccessful attempts to change, craving, time devoted to use and continuation despite consequences. It also examines whether work, relationships, health or meaningful activities are being displaced. Frequency matters, but no single frequency threshold captures every person’s level of difficulty. The context and impact are essential.
For example, a person may intend to use only after completing responsibilities, then repeatedly start earlier and abandon plans. Another may recognize that cannabis worsens anxiety but return to it whenever distress appears. These examples do not establish a diagnosis on their own. They illustrate the kinds of sequences worth discussing with a clinician who can assess the whole pattern.
Tolerance and Withdrawal
Tolerance means the person may need more to obtain an effect they previously experienced with less. Withdrawal can occur after stopping or significantly reducing regular use. It may involve irritability, anxiety, disturbed sleep, altered dreaming, low mood and reduced appetite. The NIDA marijuana withdrawal symptom checklist illustrates the range of experiences clinicians and researchers may assess.
Returning to cannabis can temporarily relieve discomfort, which may make change more difficult. That cycle is worth recognizing without treating it as a personal failure. Not everyone experiences withdrawal in the same way, and symptoms after stopping can also have other causes. A useful plan distinguishes withdrawal support from treatment of the longer-term pattern of use.
Sleep Can Become a Central Concern
People often worry that they will never sleep without cannabis. A difficult period of sleep after reducing use can strengthen that belief. However, it is important to separate the immediate adjustment from any pre-existing insomnia, irregular schedule, anxiety or other sleep problem. Assuming that all sleep difficulty proves cannabis is necessary can prevent a fuller assessment.
Describe your sleep before regular use, during use and during previous periods without it. Include caffeine, alcohol, nicotine and sleeping medicines. A clinician can consider the appropriate response to persistent sleep disturbance. Do not replace cannabis with borrowed sedatives or abrupt changes to prescribed medication simply to force sleep.
Anxiety, Low Mood and Unusual Experiences
Some people use cannabis because they feel anxious or low, while others find that use or changes in use are associated with worsening distress. The relationship can be complicated. Timing, product type, other substances and the person’s psychiatric history all need consideration. Relief in the moment does not establish that the underlying condition is being effectively treated.
Marked paranoia, hallucinations, severe confusion or an inability to remain safe needs prompt professional assessment. Immediate danger requires emergency help. For ongoing but less acute concerns, assessment should consider anxiety, depression and other relevant conditions without assuming one explanation for every symptom.
Attention, Motivation and Everyday Functioning
It can be more useful to describe concrete changes than to argue over whether cannabis makes someone lazy. Has the person stopped attending activities they value? Are conversations, appointments or deadlines harder to manage? Is more time spent recovering from use or waiting for the next opportunity? These changes can have several causes, but they are important assessment information.
A nonjudgmental record might compare intention with outcome: what you planned for the day, when use occurred and which tasks became difficult. This helps identify patterns without turning ordinary mistakes into evidence of addiction. It also creates a basis for meaningful goals, such as returning to a valued activity or reducing avoidance, rather than measuring success only through another person’s approval.
Tobacco, Alcohol and Other Drugs
Some people use cannabis with tobacco or also use nicotine separately. Changes in nicotine use can contribute to irritability, craving and sleep disturbance, making the experience harder to interpret. Tell the clinician about both substances. Alcohol, stimulants, opioids and sedatives also matter, even when they are used for different reasons or only on particular days.
The clinical review of cannabis withdrawal by Connor and colleagues emphasizes assessment of concurrent substance use and mental-health difficulties. The most urgent withdrawal risk may come from another substance. Do not assume a service can safely manage every form of withdrawal simply because it offers cannabis support.
Prescribed Cannabis Requires a Separate Conversation
A person receiving a prescribed cannabis-based medicine should discuss concerns with the prescribing clinician. The assessment needs to consider the indication, actual benefit, side effects, adherence and any use outside the plan. A prescription does not make all concerns irrelevant, but neither does needing a review automatically establish addiction.
Bring information about the formulation and instructions, other medicines and what has changed. Ask how the condition for which it was prescribed will be managed if the plan is revised. Avoid stopping or substituting prescribed treatment on the basis of a general article. Clinical decisions should account for both the original health need and any problems associated with the current pattern.
How to Prepare for an Assessment
Prepare a brief account of recent use, previous efforts to change and what you hope would be different. Include mental-health history, medication, sleep, physical symptoms and any episodes of feeling unsafe. You do not need to decide whether the correct word is habit, dependence or addiction before asking for help.
Assessment and treatment planning should establish the nature of the problem, suitable support and the reasons for the recommendation. Ask what alternatives exist, how progress will be reviewed and who will coordinate care when more than one professional is involved. A good explanation should be understandable rather than rely on a long list of therapy names.
What Treatment May Address
Treatment can explore craving, coping, expectations about cannabis, high-risk situations and the routines that keep use in place. It may also need to address an independent mental-health condition or practical pressures such as isolation and work stress. The purpose is to build a coherent plan, not simply keep someone occupied while they are away from their usual environment.
The setting should match clinical need. Local outpatient support may be appropriate for many people; others need a more structured approach or assessment of significant co-occurring difficulties. The private marijuana addiction treatment and rehab page explains how THE BALANCE considers suitability. Residential treatment is not automatically necessary for every cannabis-related concern.
Talking With Someone You Are Worried About
Choose a calm moment when the person is not intoxicated. Describe specific changes you have observed and the effect on you or the household. It is usually more productive to discuss missed commitments, distress or safety than to debate whether cannabis is universally good or bad. Suggest an assessment as a way to understand the situation.
Be clear about what support you can provide and what behavior you cannot accept. Avoid threats you cannot safely or realistically carry out. Where there is violence, coercion or immediate danger, use the appropriate safety pathway rather than attempting a joint discussion alone. Family members can seek advice for their own well-being even if the person using cannabis is not ready to change.
Withdrawal Support and Drug-Test Myths
Products advertised as cleansing cannabis from the body should not be confused with treatment. A drug-test result, the presence of metabolites and the person’s psychological or functional recovery are different questions. A negative test does not establish that craving, sleep problems or the reasons for use have been addressed.
The cannabis detox and withdrawal guide focuses on assessment, symptoms and support rather than test manipulation. Be cautious of services promising a guaranteed rapid reset. Ask what clinical care is actually provided and how the person will be supported after the initial period without cannabis.
Making Change Sustainable
Consider what role cannabis has come to play in the day: marking the end of work, making social contact easier, avoiding thoughts or filling unstructured time. A continuing-care plan should address that role with realistic alternatives and support. Removing the substance without examining its place in ordinary life can leave an important gap.
Agree what happens if use resumes, which symptoms require medical contact and when progress will be reviewed. Continuing care should encourage honest, early discussion of difficulty. A lapse is a reason to reassess the plan, not proof that change is impossible or that all previous progress has been lost.
